01- ISCHEMIA: Prognosis is Determined by Anatomy, not Functionality The ISCHEMIA study keeps providing scientific news. This work in patients with stable coronary artery disease had already shown (to our surprise) that ischemic burden does not predict 4-year mortality. Read also HERE 02- Chile Sessions 2021 | Clinical Case Contest for Young Interventionists It is with great…
Chile Sessions 2021 | Clinical Case Contest for Young Interventionists
The contest ended. The authors of the selected cases for live presentation have been contacted by email Call for Case Submission XLIII SOLACI Regional Sessions – 14th Southern Cone. Nov 27, 2021 – Chile Sessions. It is with great pleasure that we hereby invite all young Latin American cardiologists to submit relevant clinical cases related…
Watch Again Challenges in TAVR – Severe Coronary Disease and Coronary Occlusion
Watch Again Challenges in TAVR – Severe Coronary Disease and Coronary Occlusion on our youtube account. Challenges in TAVR – Severe Coronary Disease and Coronary Occlusion
SOLACI-CACI 2021 Webinar | Challenges in TAVI – Severe CAD & Coronary Occlusion
Next Thursday, October 14, we will hold a joint event between SOLACI, CACI and the Microport company on “Challenges in TAVI: Severe Coronary Disease and Coronary Occlusion”. The activity is part of the satellite events of the SOLACI-CACI 2021 Congress and, as such, will have the participation of important international and Latin American speakers. Date:…
Watch Again Advanced Strategias on Bifurcations Management in our Youtube Account
Watch Again “Advanced Strategias on Bifurcations Management” in our Youtube Account Program Provisional stent technique as a treatment philosophy: the step by step and when to use it. Critical analysis of the POT, Kissing, Re POT technique. Provisional strategy vs 2 stents in No ULM The case in which I require a second stent: when,…
The latest scientific articles on TAVI published on our website
01- TAVR and Anticoagulation: Direct Anticoagulant Agents or Vitamin K Inhibitors? In some patients, using an anticoagulant agent is not an option, it is just prescribed. Based on the French TAVR registry, this research compared long-term mortality, bleeding, and ischemic events after valve implantation. A comparison was made between TAVR and direct vs. classic anticoagulant agents—good old proven and reversible vitamin K inhibitors. Read also HERE 02-…